Cargando…

Therapeutic Effect of Epigallocatechin-3-gallate (EGCG) and Silibinin on ATM Dynamics in Prostate Cancer Cell Line LNCaP

BACKGROUND: Epigallocatechin-3-gallate (EGCG) is a major ingredient of green tea (GT) and silibinin (SB), the active component of Silymarin presumably hold a potential to prevent pathogenomics. Prostate cancer exacerbation is triggered by fusion transcripts formed because of genomic instability indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farooqi, Ammad Ahmad, Mansoor, Qaisar, Ismail, Muhammad, Bhatti, Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649750/ https://www.ncbi.nlm.nih.gov/pubmed/29147215 http://dx.doi.org/10.4021/wjon248w

Ejemplares similares

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri
por: Zhang, Yini, et al.
Publicado: (2023)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
por: Zhang, Xin, et al.
Publicado: (2016)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
por: Siblini, Hiba, et al.
Publicado: (2023)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.
por: Wolf, D. A., et al.
Publicado: (1991)

Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
por: Sohn, Hong Moon, et al.
Publicado: (2019)

Calcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
por: Wang, Jing-Huan, et al.
Publicado: (2008)

Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation
por: Minnelli, Cristina, et al.
Publicado: (2020)

Anti-proliferative activity of epigallocatechin-3-gallate and silibinin on soft tissue sarcoma cells
por: Harati, Kamran, et al.
Publicado: (2017)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
por: Mereles, Derliz, et al.
Publicado: (2011)

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
por: Du, Guang-Jian, et al.
Publicado: (2012)

Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)
por: Teng, Yu-song, et al.
Publicado: (2017)

Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)
por: Lorenz, Mario, et al.
Publicado: (2017)

Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing
por: Lin, Sung-Yen, et al.
Publicado: (2020)

Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach
por: Bainbridge, Matthew N, et al.
Publicado: (2006)

Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines
por: Seim, Inge, et al.
Publicado: (2017)

A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells
por: Briggs, Erica M., et al.
Publicado: (2019)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
por: Negri, Aide, et al.
Publicado: (2018)

Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro
por: Liu, Zhibin, et al.
Publicado: (2020)

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
por: Ferrari, Elena, et al.
Publicado: (2022)

Protective Effects of Epigallocatechin-3-gallate (EGCG) against the Jellyfish Nemopilema nomurai Envenoming
por: Li, Jie, et al.
Publicado: (2023)

The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
por: Schnur, Sabrina, et al.
Publicado: (2023)

Cholesterol Homeostasis in Two Commonly Used Human Prostate Cancer Cell-Lines, LNCaP and PC-3
por: Krycer, James Robert, et al.
Publicado: (2009)

Comparative Genomic and Transcriptomic Analyses of LNCaP and C4-2B Prostate Cancer Cell Lines
por: Spans, Lien, et al.
Publicado: (2014)

Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells
por: Cui, Luwei, et al.
Publicado: (2019)

Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation
por: Agarwal, Anshu, et al.
Publicado: (2023)

Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
por: Mirzaaghaei, Somaye, et al.
Publicado: (2019)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014)

Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: Zhang, Xianqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_09psecu1ekvrvm6bbtertqi0q6